Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




CMM and Qiagen Focus on Molecular Diagnostic Markers

By Labmedica staff writers
Posted on 13 Mar 2008
The Center for Molecular Medicine (CMM; Grand Rapids, MI, USA) and Qiagen NV (Frankfurt, Germany) have agreed to collaborate on the discovery of molecular biomarkers that will help diagnose breast cancer and other women's diseases. More...
Financial terms of the agreement were not disclosed.

CMM has access to clinical samples, molecular analysis capabilities, and XenoBase-- software and a database system developed at the Van Andel Research Institute (Grand Rapids, MI, USA). This bio-informatic system is capable of analyzing a wide range of molecular and conventional clinical data to help scientists identify clinical associations between diseases, biomarkers, and treatments. Following Qiagen's initial results, CMM might also provide laboratory-based genomics and proteomics services to assist Qiagen in the development and validation of new molecular diagnostic tests.

CMM is a Clinical Laboratory Improvement Amendments (CLIA)-certified, College of American Pathologists (CAP)-accredited, clinical diagnostics laboratory. CMM's capabilities, including XenoBase access, on-site microarray-based DNA typing, and gene expression played a role in bringing Qiagen to West Michigan.

Qiagen is a provider of sample and assay technologies and products that are considered standards in areas such pre-analytic sample preparation and assay solutions in molecular diagnostics, life sciences, and applied testing. Qiagen has developed a comprehensive range of more than 500 consumable products and automated systems for sample collection, nucleic acid and protein handling, separation, and purification, and open and target specific assays.


Related Links:
Center for Molecular Medicine
Qiagen
Van Andel Research Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.